Home > Healthcare > Medical Devices > Diagnostic Devices > Sphygmomanometer Market
Sphygmomanometer Market size crossed USD 3 billion in 2022 and is anticipated to exhibit more than 8.5% CAGR between 2023 and 2032, on account of the adoption of inactive lifestyles.
The rise in the work-from-home trend and physical inactivity are contributing to the high prevalence of cardiovascular diseases. According to the WHO, in 2021, cardiovascular conditions accounted for over 18 million deaths annually. This high disease burden will spur the development of vital signs monitoring devices including blood pressure sphygmomanometers since hypertension is a common risk factor for CVDs. High blood pressure, which affects nearly a billion people, substantially elevates the risk of heart, brain, kidney, and other diseases. The adoption of sedentary lifestyles will also accelerate the use of electronic sphygmomanometers.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Sphygmomanometer Market Size in 2022: | USD 3 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 8.5% |
2032 Value Projection: | USD 7 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 360 |
Tables, Charts & Figures: | 833 |
Segments covered: | Product, Operation, Configuration, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
With rapid technological advancement, medical devices for use in homecare settings are gaining momentum, creating growth opportunities for sphygmomanometer developers. However, there has been growing awareness of product inaccuracy through various validation, calibration, and inspection protocols.